{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T08:49:27Z","timestamp":1777625367019,"version":"3.51.4"},"reference-count":57,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["001"],"award-info":[{"award-number":["001"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","award":["447120\/2014-0"],"award-info":[{"award-number":["447120\/2014-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"State of Sao Paulo Research Foundation","doi-asserted-by":"publisher","award":["2016\/12899-6"],"award-info":[{"award-number":["2016\/12899-6"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jpet.2025.103626","type":"journal-article","created":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T10:56:35Z","timestamp":1749293795000},"page":"103626","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Statin treatment alters the expression profile of plasma exosome-derived microRNAs in patients with familial hypercholesterolemia"],"prefix":"10.1016","volume":"392","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2109-9399","authenticated-orcid":false,"given":"Carolina","family":"Dagli-Hernandez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renata Caroline Costa de","family":"Freitas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andre Ducati","family":"Luchessi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thiago Dominguez Crespo","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina Moreno","family":"Fajardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica Bassani","family":"Borges","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3156-0249","authenticated-orcid":false,"given":"Victor Fernandes de","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonia Pereira","family":"Rosa Neta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andre Arpad","family":"Faludi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo Marques","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raul Hernandes","family":"Bortolin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2466-1615","authenticated-orcid":false,"given":"Vanessa Barbosa","family":"Malaquias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gisele Medeiros","family":"Bastos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcelo Ferraz","family":"Sampaio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario Hiroyuki","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3073-5967","authenticated-orcid":false,"given":"Rosario Dominguez Crespo","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jpet.2025.103626_bib1","first-page":"16","article-title":"Primary and secondary prevention of CAD: a review","volume":"31","author":"Short","year":"2021","journal-title":"Int J Angiol"},{"key":"10.1016\/j.jpet.2025.103626_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2020.105735","article-title":"Statins reduce vascular inflammation in atherogenesis: a review of underlying molecular mechanisms","volume":"122","author":"Liberale","year":"2020","journal-title":"Int J Biochem Cell Biol"},{"issue":"4","key":"10.1016\/j.jpet.2025.103626_bib3","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1080\/07853890.2018.1457795","article-title":"Molecular aspects of hypercholesterolemia treatment: current perspectives and hopes","volume":"50","author":"Ahangari","year":"2018","journal-title":"Ann Med"},{"issue":"9","key":"10.1016\/j.jpet.2025.103626_bib4","doi-asserted-by":"crossref","first-page":"877","DOI":"10.3390\/jpm11090877","article-title":"Pharmacogenomics variability of lipid-lowering therapies in familial hypercholesterolemia","volume":"11","author":"Hindi","year":"2021","journal-title":"J Pers Med"},{"issue":"11","key":"10.1016\/j.jpet.2025.103626_bib5","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.tips.2018.09.005","article-title":"MicroRNAs: novel molecular targets and response modulators of statin therapy","volume":"39","author":"Mohajeri","year":"2018","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.jpet.2025.103626_bib6","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.biochi.2020.02.006","article-title":"The complex interplay between DNA methylation and miRNAs in gene expression regulation","volume":"173","author":"Fuso","year":"2020","journal-title":"Biochimie"},{"issue":"12","key":"10.1016\/j.jpet.2025.103626_bib7","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13388","article-title":"Statins: epidrugs with effects on endothelial health?","volume":"50","author":"Mohammadzadeh","year":"2020","journal-title":"Eur J Clin Invest"},{"issue":"11","key":"10.1016\/j.jpet.2025.103626_bib8","doi-asserted-by":"crossref","first-page":"9165","DOI":"10.1007\/s11033-023-08784-9","article-title":"LDLR and PCSK9 3\u02b9UTR variants and their putative effects on microRNA molecular interactions in familial hypercholesterolemia: a computational approach","volume":"50","author":"de Freitas","year":"2023","journal-title":"Mol Biol Rep"},{"issue":"9","key":"10.1016\/j.jpet.2025.103626_bib9","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20201885","article-title":"Statin-induced microRNAome alterations modulating inflammation pathways of peripheral blood mononuclear cells in patients with hypercholesterolemia","volume":"40","author":"Lin","year":"2020","journal-title":"Biosci Rep"},{"key":"10.1016\/j.jpet.2025.103626_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.674252","article-title":"MicroRNA-33b is a potential non-invasive biomarker for response to atorvastatin treatment in Chilean subjects with hypercholesterolemia: a pilot study","volume":"12","author":"Ubilla","year":"2021","journal-title":"Front Pharmacol"},{"issue":"9","key":"10.1016\/j.jpet.2025.103626_bib11","doi-asserted-by":"crossref","first-page":"5022","DOI":"10.3390\/ijms23095022","article-title":"MicroRNA-20a-5p downregulation by atorvastatin: a potential mechanism involved in lipid-lowering therapy","volume":"23","author":"Saavedra","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"10","key":"10.1016\/j.jpet.2025.103626_bib12","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11883-020-00871-7","article-title":"Exosomes: multifaceted messengers in atherosclerosis","volume":"22","author":"Wang","year":"2020","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.jpet.2025.103626_bib13","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cca.2016.12.031","article-title":"Relationship between circulating microRNA-30c with total- and LDL-cholesterol, their circulatory transportation and effect of statins","volume":"466","author":"Sodi","year":"2017","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jpet.2025.103626_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2023.147501","article-title":"Identification of pathogenic variants in the Brazilian cohort with familial hypercholesterolemia using exon-targeted gene sequencing","volume":"875","author":"Borges","year":"2023","journal-title":"Gene"},{"issue":"4","key":"10.1016\/j.jpet.2025.103626_bib15","first-page":"782","article-title":"Update of the Brazilian guideline for familial hypercholesterolemia - 2021","volume":"117","author":"Izar","year":"2021","journal-title":"Arq Bras Cardiol"},{"issue":"5","key":"10.1016\/j.jpet.2025.103626_bib16","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.jpet.2025.103626_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bdq.2017.11.002","article-title":"Small sample sizes in high-throughput miRNA screens: a common pitfall for the identification of miRNA biomarkers","volume":"15","author":"Kok","year":"2017","journal-title":"Biomol Detect Quantif"},{"issue":"3","key":"10.1016\/j.jpet.2025.103626_bib18","article-title":"Lipid-lowering efficacy of atorvastatin","volume":"2015","author":"Adams","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jpet.2025.103626_bib19","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.atherosclerosis.2020.12.023","article-title":"Combination of bempedoic acid, ezetimibe, and atorvastatin in patients with hypercholesterolemia: A randomized clinical trial","volume":"320","author":"Rubino","year":"2021","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jpet.2025.103626_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2025.120123","article-title":"Integrative analysis of miRNAs and proteins in plasma extracellular vesicles of patients with familial hypercholesterolemia","volume":"568","author":"Freitas","year":"2025","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jpet.2025.103626_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/srep25749","article-title":"miARma-Seq: a comprehensive tool for miRNA, mRNA and circRNA analysis","volume":"6","author":"Andr\u00e9s-Le\u00f3n","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jpet.2025.103626_bib22","author":"Andrews"},{"issue":"4","key":"10.1016\/j.jpet.2025.103626_bib57","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.1923","article-title":"Fast gapped-read alignment with Bowtie 2","volume":"9","author":"Langmead","year":"2012","journal-title":"Nat Methods"},{"issue":"7","key":"10.1016\/j.jpet.2025.103626_bib58","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","article-title":"featureCounts: an efficient general purpose program for assigning sequence reads to genomic features","volume":"30","author":"Liao","year":"2014","journal-title":"Bioinformatics"},{"issue":"12","key":"10.1016\/j.jpet.2025.103626_bib24","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"issue":"D1","key":"10.1016\/j.jpet.2025.103626_bib25","doi-asserted-by":"crossref","first-page":"D147","DOI":"10.1093\/nar\/gkae1072","article-title":"miRTarBase 2025: updates to the collection of experimentally validated microRNA-target interactions","volume":"53","author":"Cui","year":"2025","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"10.1016\/j.jpet.2025.103626_bib26","doi-asserted-by":"crossref","first-page":"W234","DOI":"10.1093\/nar\/gkz240","article-title":"NetworkAnalyst 3.0: a visual analytics platform for comprehensive gene expression profiling and meta-analysis","volume":"47","author":"Zhou","year":"2019","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"10.1016\/j.jpet.2025.103626_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/cpz1.90","article-title":"Gene set knowledge discovery with Enrichr","volume":"1","author":"Xie","year":"2021","journal-title":"Curr Protoc"},{"issue":"2","key":"10.1016\/j.jpet.2025.103626_bib28","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1515\/mr-2021-0001","article-title":"MicroRNAs in cardiovascular diseases","volume":"2","author":"Li","year":"2022","journal-title":"Med Rev (2021)"},{"issue":"7","key":"10.1016\/j.jpet.2025.103626_bib29","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s00018-022-04406-y","article-title":"miRNA-486-5p: signaling targets and role in non-malignant disease","volume":"79","author":"Douvris","year":"2022","journal-title":"Cell Mol Life Sci"},{"issue":"4","key":"10.1016\/j.jpet.2025.103626_bib30","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s11033-018-4186-8","article-title":"Inhibition of miR-486 and miR-92a decreases liver and plasma cholesterol levels by modulating lipid-related genes in hyperlipidemic hamsters","volume":"45","author":"Niculescu","year":"2018","journal-title":"Mol Biol Rep"},{"issue":"4","key":"10.1016\/j.jpet.2025.103626_bib31","first-page":"3298","article-title":"MiR-30e and miR-92a are related to atherosclerosis by targeting ABCA1","volume":"19","author":"Wang","year":"2019","journal-title":"Mol Med Rep"},{"issue":"12 Pt B","key":"10.1016\/j.jpet.2025.103626_bib32","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1016\/j.bbalip.2016.01.013","article-title":"MicroRNAs as regulators of endothelial cell functions in cardiometabolic diseases","volume":"1861","author":"Araldi","year":"2016","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"10.1016\/j.jpet.2025.103626_bib33","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1016\/j.ygeno.2021.05.036","article-title":"Integrated analysis of microRNA and mRNA expression profiles in homozygous familial hypercholesterolemia patients and validation of atherosclerosis associated critical regulatory network","volume":"113","author":"Wu","year":"2021","journal-title":"Genomics"},{"issue":"10","key":"10.1016\/j.jpet.2025.103626_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0140958","article-title":"MiR-486 and miR-92a identified in circulating HDL discriminate between stable and vulnerable coronary artery disease patients","volume":"10","author":"Niculescu","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jpet.2025.103626_bib35","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20170047","article-title":"Circulating endothelial microparticles and miR-92a in acute myocardial infarction","volume":"37","author":"Zhang","year":"2017","journal-title":"Biosci Rep"},{"issue":"1","key":"10.1016\/j.jpet.2025.103626_bib36","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-56857-2","article-title":"Analysis of HDL-microRNA panel in heterozygous familial hypercholesterolemia subjects with LDL receptor null or defective mutation","volume":"9","author":"Scicali","year":"2019","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.jpet.2025.103626_bib37","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.3390\/genes14081571","article-title":"Long-term LDL-apheresis treatment and dynamics of circulating miRNAs in patients with severe familial hypercholesterolemia","volume":"14","author":"Dlouha","year":"2023","journal-title":"Genes (Basel)"},{"issue":"4","key":"10.1016\/j.jpet.2025.103626_bib38","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1161\/CIRCRESAHA.115.306300","article-title":"MicroRNA regulation of atherosclerosis","volume":"118","author":"Feinberg","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.jpet.2025.103626_bib39","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.vph.2018.06.011","article-title":"Non-coding RNAs in lipid metabolism","volume":"114","author":"Zhang","year":"2019","journal-title":"Vascul Pharmacol"},{"issue":"3","key":"10.1016\/j.jpet.2025.103626_bib40","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.ncrna.2024.02.017","article-title":"Profiling of differentially expressed microRNAs in familial hypercholesterolemia via direct hybridization","volume":"9","author":"Cione","year":"2024","journal-title":"Noncoding RNA Res"},{"key":"10.1016\/j.jpet.2025.103626_bib41","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.atherosclerosissup.2017.05.037","article-title":"Analysis of circulating miRNAs in patients with familial hypercholesterolaemia treated by LDL\/Lp(a) apheresis","volume":"30","author":"Dlouha","year":"2017","journal-title":"Atheroscler Suppl"},{"issue":"8","key":"10.1016\/j.jpet.2025.103626_bib42","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.2337\/db16-1405","article-title":"Protective effect of let-7 miRNA family in regulating inflammation in diabetes-associated atherosclerosis","volume":"66","author":"Brennan","year":"2017","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.jpet.2025.103626_bib43","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1186\/s12935-022-02754-0","article-title":"A review on the role of mir-16-5p in the carcinogenesis","volume":"22","author":"Ghafouri-Fard","year":"2022","journal-title":"Cancer Cell Int"},{"issue":"7","key":"10.1016\/j.jpet.2025.103626_bib44","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1152\/physiolgenomics.00087.2023","article-title":"Specific circulating miRNAs are associated with plasma lipids in a healthy American cohort","volume":"56","author":"Evans","year":"2024","journal-title":"Physiol Genomics"},{"key":"10.1016\/j.jpet.2025.103626_bib45","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ejps.2018.02.007","article-title":"Statins differentially modulate microRNAs expression in peripheral cells of hyperlipidemic subjects: a pilot study","volume":"117","author":"Zambrano","year":"2018","journal-title":"Eur J Pharm Sci"},{"issue":"3","key":"10.1016\/j.jpet.2025.103626_bib46","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1177\/1535370215605588","article-title":"MicroRNAs as biomarkers of hepatotoxicity in a randomized placebo-controlled study of simvastatin and ubiquinol supplementation","volume":"241","author":"Pek","year":"2016","journal-title":"Exp Biol Med (Maywood)"},{"issue":"1","key":"10.1016\/j.jpet.2025.103626_bib47","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.bbrc.2010.12.119","article-title":"Dysregulation of angiogenesis-related microRNAs in endothelial progenitor cells from patients with coronary artery disease","volume":"405","author":"Zhang","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10.1016\/j.jpet.2025.103626_bib48","doi-asserted-by":"crossref","first-page":"817","DOI":"10.3892\/mmr.2017.6616","article-title":"Atheroprotective effects of statins in patients with unstable angina by regulating the blood-borne microRNA network","volume":"16","author":"Li","year":"2017","journal-title":"Mol Med Rep"},{"issue":"23","key":"10.1016\/j.jpet.2025.103626_bib49","doi-asserted-by":"crossref","first-page":"9036","DOI":"10.1002\/cam4.3557","article-title":"Functional mechanism and clinical implications of microRNA-423 in human cancers","volume":"9","author":"Ke","year":"2020","journal-title":"Cancer Med"},{"issue":"7","key":"10.1016\/j.jpet.2025.103626_bib50","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1253\/circj.CJ-19-1181","article-title":"Circulating microRNA-423-3p improves the prediction of coronary artery disease in a general population\u2014six-year follow-up results from the China-Cardiovascular Disease Study","volume":"84","author":"Wang","year":"2020","journal-title":"Circ J"},{"issue":"5","key":"10.1016\/j.jpet.2025.103626_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0216363","article-title":"MiR-423 is differentially expressed in patients with stable and unstable coronary artery disease: a pilot study","volume":"14","author":"Rizzacasa","year":"2019","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jpet.2025.103626_bib52","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s40169-019-0240-y","article-title":"Let-7 as biomarker, prognostic indicator, and therapy for precision medicine in cancer","volume":"8","author":"Chirshev","year":"2019","journal-title":"Clin Transl Med"},{"key":"10.1016\/j.jpet.2025.103626_bib53","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.biopha.2018.12.123","article-title":"Insight into miRNAs related with glucometabolic disorder","volume":"111","author":"Zhang","year":"2019","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"10.1016\/j.jpet.2025.103626_bib54","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.24380","article-title":"Circulating microRNAs as predictive biomarkers of coronary artery diseases in type 2 diabetes patients","volume":"36","author":"Mahjoob","year":"2022","journal-title":"J Clin Lab Anal"},{"issue":"5","key":"10.1016\/j.jpet.2025.103626_bib55","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3892\/mmr.2023.13090","article-title":"Serum-derived exosomal hsa-let-7b-5p as a biomarker for predicting the severity of coronary stenosis in patients with coronary heart disease and hyperglycemia","volume":"28","author":"Han","year":"2023","journal-title":"Mol Med Rep"},{"issue":"2","key":"10.1016\/j.jpet.2025.103626_bib56","doi-asserted-by":"crossref","first-page":"637","DOI":"10.3390\/ijms26020637","article-title":"Characterizing circulating microRNA signatures of type 2 diabetes subtypes","volume":"26","author":"Sulaiman","year":"2025","journal-title":"Int J Mol Sci"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356525398393?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356525398393?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:01:24Z","timestamp":1777420884000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356525398393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":57,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0022356525398393"],"URL":"https:\/\/doi.org\/10.1016\/j.jpet.2025.103626","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Statin treatment alters the expression profile of plasma exosome-derived microRNAs in patients with familial hypercholesterolemia","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpet.2025.103626","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103626"}}